Expert Opinion on Drug Discovery, Volume 12, Issue 6 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 12, Issue 6 (2017)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Volume 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
Academia–pharma partnerships for novel drug discovery: essential or nice to have?
Michelle Palmer & Rathnam Chaguturu
Pages: 537-540
Published online: 17 Apr 2017
First Page PreviewforAcademia–pharma partnerships for novel drug discovery: essential or nice to have? | Full Text | References | PDF (335.2 KB)
  • 10530 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Applications of CRISPR genome editing technology in drug target identification and validation
Quinn Lu, George P. Livi, Sundip Modha, Kosuke Yusa, Ricardo Macarrón & David J. Dow
Pages: 541-552
Published online: 23 Apr 2017
AbstractforApplications of CRISPR genome editing technology in drug target identification and validation | Full Text | References | PDF (1.1 MB)
  • 1051 Views
  • 13 CrossRef citations
  • 0Altmetric
Review
Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design
Amanda T.S. Albanaz, Carlos H.M. Rodrigues, Douglas E.V. Pires & David B. Ascher
Pages: 553-563
Published online: 11 May 2017
AbstractforCombating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design | Full Text | References | PDF (1.4 MB)
  • 285 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Therapeutic targeting and patient selection for cancers with homologous recombination defects
Francien Talens, Mathilde Jalving, Jourik A. Gietema & Marcel A. Van Vugt
Pages: 565-581
Published online: 02 May 2017
AbstractforTherapeutic targeting and patient selection for cancers with homologous recombination defects | Full Text | References | PDF (1.8 MB)
  • 4295 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access
Review
An overview of quinoline as a privileged scaffold in cancer drug discovery
Robert Musiol
Pages: 583-597
Published online: 20 Apr 2017
AbstractforAn overview of quinoline as a privileged scaffold in cancer drug discovery | Full Text | References | PDF (1.3 MB)
  • 575 Views
  • 151 CrossRef citations
  • 0Altmetric
Review
‘Big data’ approaches for novel anti-cancer drug discovery
Graeme Benstead-Hume, Sarah K. Wooller & Frances M. G. Pearl
Pages: 599-609
Published online: 02 May 2017
Abstractfor‘Big data’ approaches for novel anti-cancer drug discovery | Full Text | References | PDF (1 MB)
  • 458 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Enhancing the therapeutic potential of peptide toxins
Raymond S. Norton
Pages: 611-623
Published online: 20 Apr 2017
AbstractforEnhancing the therapeutic potential of peptide toxins | Full Text | References | PDF (1.4 MB)
  • 596 Views
  • 38 CrossRef citations
  • 0Altmetric
Review
An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
Wooseong Kim, Gabriel Lambert Hendricks, Kiho Lee & Eleftherios Mylonakis
Pages: 625-633
Published online: 21 Apr 2017
AbstractforAn update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs | Full Text | References | PDF (1.4 MB)
  • 652 Views
  • 30 CrossRef citations
  • 0Altmetric

Drug Discovery Case History

Article
Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
Mohamed El Kassas, Tamer Elbaz, Enas Hafez, Mohamed Naguib Wifi & Gamal Esmat
Pages: 635-642
Published online: 05 May 2017
AbstractforDiscovery and preclinical development of dasabuvir for the treatment of hepatitis C infection | Full Text | References | PDF (824.3 KB)
  • 224 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng et al.
Review Article | Published online: 12 Jul 2024
View all latest articles